XML 88 R73.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Details) - USD ($)
1 Months Ended 12 Months Ended
Mar. 24, 2010
May. 31, 2015
Mar. 24, 2012
Sep. 28, 2011
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Aug. 01, 2015
Jul. 31, 2015
Jun. 30, 2015
May. 31, 2014
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets         $ 670,833 $ 474,568          
Ownership percentage by parent                   91.00% 85.00%
Payment of receivable   $ 1,000,000                  
Future payments to be received   $ 1,000,000                  
Percentage of ownership   20.00%                  
Maximum additional equity fundraising   $ 10,000,000                  
Investment in affiliated entity - PLS         5,045,915 0          
Plumbline Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Carrying value of investment                     $ 0
Investment in affiliated entity - PLS         $ 5,000,000            
Available-for-sale Securities | Plumbline Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Number of shares owned         395,758     395,758      
Ownership               16.90%      
VGX Pharmaceuticals | Available-for-sale Securities                      
Related-Party Transactions (Textual) [Abstract]                      
Number of shares owned                 465,364    
GeneOne (affiliated entity)                      
Related-Party Transactions (Textual) [Abstract]                      
Payment received for license granted $ 3,000,000                    
Deferred revenue from affiliated entity $ 3,000,000                    
Period over which deferred revenue from affiliated entity will be recognized in years 8 years                    
Accounts payable/accrued liability         $ 165,000 28,000          
NIAID                      
Related-Party Transactions (Textual) [Abstract]                      
Revenue from related parties         450,000 479,000 $ 425,000        
Operating expenses related to affiliated entity         6,900,000 4,200,000 $ 2,300,000        
Accounts receivable from related parties         4,000 2,000          
Long-term other assets         $ 373,000 $ 260,000          
Percentage of ownership         10.20% 10.20%          
OncoSec | First warrant                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (shares)       50,000              
Term of the warrants in years       5 years              
Exercise price of a five-year warrant ($ per share)       $ 24.00              
OncoSec | Second warrant                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (shares)     150,000                
Term of the warrants in years     5 years                
Exercise price of a five-year warrant ($ per share)     $ 20.00